Santen Pharmaceutical saw the highest growth of 0.99% in patent filings and 1.32% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.66% and grants by 0.74%. GlobalData’s DataBook provides a comprehensive analysis of Santen Pharmaceutical’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Santen Pharmaceutical has been focused on protecting inventions in United States(US) with five publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 25% filings and 40% grants. The South Korea(KR), United States(US), European Patent Office(EPO), and Spain(ES) patent Office are among the top ten patent offices where Santen Pharmaceutical is filings its patents. Among the top granted patent authorities, Santen Pharmaceutical has 40% of its grants in United States(US), 30% in Spain(ES) and 20% in Canada(CA).
AbbVie and Regeneron Pharmaceuticals could be the strongest competitors for Santen Pharmaceutical
Patents related to climate change and rare diseases lead Santen Pharmaceutical's portfolio
Santen Pharmaceutical has the highest number of patents in climate change followed by, rare diseases. For climate change no patents were filed and 50% of patents were granted in Q2 2024.
Glaucoma related patents lead Santen Pharmaceutical portfolio followed by ocular hypertension, and hypertension
Santen Pharmaceutical has highest number of patents in glaucoma followed by ocular hypertension, hypertension, keratoconjunctivitis sicca (dry eye), and neovascular glaucoma.
For comprehensive analysis of Santen Pharmaceutical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
